February/March 2015• Current Issue

Opening Thoughts
The Top 10 Most Expensive Convertibles

Wall Street View
Dream Drugs

Novartis Pharmaceuticals
To Care and Cure: A Discussion with President Timothy Maloney

Gallant Leaman Group
After Ten Years

Market Insights: Beyond 2015
To Be or Not To Be — The Future of Pharmaceutical Field Force Deployment  

Getting the Most Out of Technology for Multichannel Marketing:
Automate, Learn, Adapt

An IMS Brogan Viewpoint

Gallant Leaman Group Announcement

Advertising Analysis Review

People on the Move